The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PD-1:PD-L1(B7-H1) pathway in adaptive resistance: A novel mechanism for tumor immune escape in human papillomavirus-related head and neck cancers.
Sofia Lyford-Pike
No relevant relationships to disclose
Shiwen Peng
No relevant relationships to disclose
Janis M. Taube
No relevant relationships to disclose
William H. Westra
No relevant relationships to disclose
Belinda Akpeng
No relevant relationships to disclose
Hao Wang
No relevant relationships to disclose
Charles G. Drake
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Lieping Chen
No relevant relationships to disclose
Suzanne Louise Topalian
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Drew M. Pardoll
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb (I)
Sara I Pai
No relevant relationships to disclose